U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number: 000-56551
☐ | Form 10-K | ☐ | Form 20-F | ☐ | Form 11-K | ☒ | Form 10-Q | ☐ | Form 10-D | ☐ | Form N-SAR | ☐ | Form N-CSR |
For period ended: September 30, 2023
☐ | Transition Report on Form 10-K |
☐ | Transition Report on Form 20-F |
☐ | Transition Report on Form 11-K |
☐ | Transition Report on Form 10-Q |
☐ | Transition Report on Form N-SAR |
For the Transition Period Ended: N/A
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ________________
PART I - REGISTRANT INFORMATION
The Healing Company Inc. |
|
Full Name of Registrant |
|
|
|
| N/A |
|
Former Name if Applicable: |
|
|
|
135 West 50th Street, 2nd Floor |
|
Address of Principal Executive Office (Street and Number): |
|
|
|
New York, New York 10020 |
|
City, State and Zip Code |
|
PART II - RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
☒ | (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
☒ | (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
☐ | (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached, if applicable. |
PART III - NARRATIVE
The Healing Company Inc. (the “Registrant”) is unable to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2023, without unreasonable effort and expense. The delay in completion of the report is a result of additional time required to compile information with respect to the Company’s recently acquired operating subsidiaries. The Registrant expects to file the Form 10-Q on or before Monday, November 20, 2023.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification:
Justin Figgins |
| (866) |
| 241-0670 |
(Name) |
| (Area Code) |
| (Telephone Number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes ☒ No ☐
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ☒ No ☐
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
During the comparative three months ended September 30, 2023, the Company expects to report substantial increases in operating revenues, costs of goods and operating costs including management fees, professional fees, consulting fees, stock-based compensation, and other operational overhead as compared to the three months ended September 30, 2022. On October 13, 2022, the Company concluded the acquisition of assets of Your Super Inc. including several operating entities and on March 1, 2023, the Company completed the acquisitions of certain assets from Chopra Global LLC. As of the date of this Report, the Company has not yet completed the consolidated accounts, including some restructuring items and finalization of revenue recognition and other income.
| 2 |
The Healing Company Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: November 14, 2023 | By: | /s/ Justin Figgins | |
|
| Justin Figgins | |
Interim Chief Financial Officer (Principal Financial and Accounting Officer) |
| 3 |
